In a new job - May 17, 2021
Hemispherian forms a Clinical Advisory Board
Hemispherian has announced the formation of its Clinical Advisory Board (CAB) by appointing world leaders in brain cancer. The advisory board will provide external advice, guidance, and support to the company, shaping the continuing preclinical and clinical development of the GLIX family of anticancer pharmaceuticals, states the company in a press release. “I am thrilled […]